Roshanak Monzavi

Roshanak Monzavi, MD is a Clinical Professor of Pediatrics at the University of Southern California (USC), affiliated with Children’s Hospital Los Angeles (CHLA). Her clinical and research focus centers on pediatric endocrinology, particularly type 1 diabetes management, health-related quality of life assessment, and clinical trials evaluating interventions for metabolic disorders. She specializes in advancing patient-centered outcomes research through innovative measurement tools like the Type 1 Diabetes and Life (T1DAL) measures.

Her work emphasizes translational research in immunotherapy for new-onset type 1 diabetes, including trials with alefacept and abatacept. She has also investigated the role of continuous glucose monitoring (CGM) in improving glycemic control among adolescents and young adults, demonstrating durable benefits over 12 months. Additional research interests include pediatric endocrine conditions such as congenital adrenal hyperplasia and metabolic syndrome.

Dr. Monzavi’s contributions span over two decades, with publications addressing vitamin D’s impact on diabetes, caregiver burden in type 1 diabetes families, and conference highlights from major endocrine meetings. Her research integrates clinical care innovations with rigorous psychometric validation of patient-reported outcome measures.

Her advising and grant activities include involvement in NIH-funded clinical trials and collaborative efforts with the Clinical and Translational Science Institute (CTSI). Though no specific awards are listed, her sustained publication record reflects ongoing contributions to pediatric endocrinology and diabetes care advancements. She actively participates in academic conferences, ensuring clinical practice aligns with emerging research.